US News

Company said to be ‘Broadening patent portfolio for xxtended-release amantadine’ Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS), today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,796,337, entitled “Composition and Method For Treating Neurological Disease.” The claims of this patent are directed towards methods for treating...

Breaking News: Winthrop Realty Trust (NYSE:FUR) has announced that at its special meeting of common shareholders held earlier in the day holders of approximately 73% of Winthrop’s common shares of beneficial interest approved the plan of liquidation previously adopted by Winthrop’s Board of Trustees. As a result, the plan of liquidation was approved by the […]

Public Offering of 7.375% Senior Notes due 2021 Arbor Realty Trust, Inc. (NYSE:ABR) announced today that it has priced its public offering of $35.0 million aggregate principal amount of its 7.375% Senior Notes due 2021 for gross proceeds of $33.88 million. The offering was made pursuant to a reopening of its existing series of such […]

Patriot National Bancorp, Inc. (Nasdaq:PNBK) reported net income of $525,000 or $0.01 per diluted share for the second quarter of 2014. The results compare to net income of $319,000 in the first quarter of this year, (a 65% increase) and compared to a net loss of $3,912,000 in the second quarter of 2013. Excluding a […]

We have tended to be keen on the prospects of Gulf Keystone Petroleum (LSE:GKP) and its project in the Shaikan field in Kurdistan. The fact is that we still are, but the conflict in bordering Iraq, spurred by the so-called Islamic State’s pursuit of toppling the al-Maliki government in Iraq and establishing a caliphate in […]

Imagine that you are a blind man standing in front of a life-sized braille version of the 3D Systems Corp (NYSE:DDD) stock chart. Imagine that you reach out and locate the share price as of 02 January 2014. At 94.19, it is just about at shoulder height. Now imagine that you begin to trace the […]

Phase 1b PROVIDE Study in Pediatric Patients with Inherited Metabolic Disorders Expected to Begin in 4Q14 Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug Application […]

M/A-COM Technology Solutions Holdings, Inc. (Nasdaq:MTSI), a leading supplier of high performance analog semiconductor solutions, today reported its financial results for its fiscal third quarter ended July 4, 2014. Third Quarter Fiscal Year 2014 GAAP Results: – Revenue was $112.4 million, compared to $107.8 million in the prior fiscal quarter and $83.5 million in the […]

Secures £1,750,000 Loan on Attractive Terms – February 2015 Trial Date Set for Legal action Against Fitbit Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, has announced that NW1 Investments Limited and Kifin Limited , a Kirsh Group subsidiary have together agreed to loan £1,750,000 to the Company. The […]

Whether you look at its share price or its operational reports, Reckitt Benckiser LSE:RB.) simply continues to impress. It’s share price finished up today by 2.66%, a gain of 135.00 pence from Friday’s close of 5,070. Shares closed today at 5,205 after opening at 5,170 and reaching an intra-day high of 5,250, just shy of […]